CAS: 71936-92-0; 1,2,3,4,10,14B-Hexahydrodibenzo[c,F]Pyrazino[1,2-A]Azepine

该化合物是一种化学化合物,在结构上与抗抑郁素(抗抑郁剂)有关,其特征是分子结构,包括二苯环乙苯乙烯核心,以其药理特性而著称,特别是作为血清素受体的对立体.Demotymisanerin展示了各种...

结构式图片

MSDS等安全信息

    上下游产品

    N-Cyanomianserin mianserin 2-(6,11-dihydro-5H-dibenzo[b,e]azepin-6-ylmethyl)isoindole-1,3-dione 2-benzylanilinemianserinmianserin (14BR)-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine mianserin

    合成工艺路线路线简述

    • 合成目标产物 Desmethylmianserin 主要起始原料 Benzaldehyde, 2-[(Phenylmethyl)Amino]-
    • (文献来源)合成步骤主要原料 Benzaldehyde, 2-[(Phenylmethyl)Amino]-

    海关参考信息

    专利信息


    专利号:WO-2023284262-A1
    优先权日:2021-07-13
    标 题 :3,4-fused seven-membered heterocyclic oxindole, synthesis method therefor and application thereof
    发明人:Li shuai-shuai; HU FANGZHI; Ding Zhanshuai; LI XINYAO
    权利人:UNIV QINGDAO AGRICULTURAL
    摘要:Disclosed is a 3,4-fused seven-membered heterocyclic oxindole, a synthesis method therefor and an application thereof. A structure of a 3,4-fused seven-membered nitrogen heterocyclic oxindole is provided in the present invention. A method for synthesizing same is also provided, comprising the following steps: reacting propargyl alcohol containing an isatin framework with a nucleophile under specific conditions to prepare a 3,4-fused seven-membered nitrogen heterocyclic oxindole. A pharmaceutical composition is provided in the present invention. Also provided in the present invention is an application of a 3,4-fused seven-membered nitrogen heterocyclic oxindole in the preparation of a drug for treating cancer. Provided in the present invention is a method for efficiently synthesizing 3,4-fused seven-membered nitrogen heterocyclic oxindoles having different structures. This is the first time achieving efficient synthesis of bioactive molecules containing both benzazepine and 3,4-fused heterooxidized oxindole structures on the basis of a hydrogen migration strategy.

    专利号:US-4217452-A
    优先权日:1974-02-09
    标 题:Synthesis for the preparation of tetracyclic compounds
    发明人:OLIVIE JACQUES
    权利人:AKZONA INC
    摘要:The invention relates to a new synthesis for the preparation of tetracyclic compounds of the general formula: ##STR1## as well as the pharmaceutically acceptable salts thereof, in which: n is the number 1 or 2, n m is the number 1, if n=2 and the number 2, if n=1, n R 1 and R 2 stand for hydrogen, hydroxy, halogen, lower alkyl (1-4 C), lower alkoxy (1-4 C) or trifluoromethyl and n R 3 represents hydrogen, alkyl (1-6 C), aralkyl (7-10 C) or an amino alkyl group (1-6 C), in which the nitrogen atom has been substituted by two alkyl groups (1-4 C), or the nitrogen atom forms part of a heterocyclic 5- or 6-membered ring, n having valuable biological properties.

    专利号:US-4254031-A
    优先权日:1974-02-09
    标 题:Synthesis for the preparation of tetracyclic compounds
    发明人:OLIVIE JACQUES
    权利人:AKZONA INC
    摘要:The invention relates to a new synthesis for the preparation of tetracyclic compounds of the general formula ##STR1## as well as the pharmaceutically acceptable salts thereof, in which: n is the number 1 or 2, n m is the number 1, if n=2 and the number 2, if n=1, n R 1 and R 2 stand for hydrogen, hydroxy, halogen, lower alkyl (1-4 C), lower alkoxy (1-4 C) or trifluoromethyl and n R 3 represents hydrogen, alkyl (1-6 C), aralkyl (7-10 C) or an amino alkyl group (1-6 C), in which the nitrogen atom has been substituted by two alkyl groups (1-4 C), or the nitrogen atom forms part of a heterocyclic 5- or 6-membered ring, n having valuable biological properties.

    专利号:US-4025513-A
    优先权日:1974-02-09
    标题:Synthesis for the preparation of tetracyclic compounds

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00406-006-0663-5
    摘要:Thuerauf N, Lunkenheimer J. The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants. European Archives of Psychiatry and Clinical Neuroscience. 2006 Jun 16;256(5):287–93. doi: 10.1007/s00406-006-0663-5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知